According to ingenuity pathway analysis, ANO1 modulates the antiangiogenic factor insulin-like growth factor-binding protein 5 (IGFBP5), which in turn regulates IGF/IGFR signalling in the tumour microenvironment and hence promotes tumour growth (91). The gene discussed is IGFBP5; the disease is neoplasm.